RPS19 and idiopathic aplastic anemia: On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the European Group for Blood and Marrow Transplantation, Diaz-de-Heredia et al. reinforced that stem cell transplantation should be provided to all children with an available matched family donor who is not a DBA silent phenotype [7].